The Globe and Mail reports in its Thursday, May 21, edition that two generic versions of Ozempic are set to start arriving in Canadian pharmacies this week, which means patients who use the drug to treat diabetes or for weight loss may have more options for a fraction of the cost. A Canadian Press dispatch to The Globe reports that Health Canada approved both Dr. Reddy's Laboratories and Apotex's generic semaglutide -- the active ingredient in brand-name Ozempic -- about three weeks ago. Apotex is based in Canada and says it began shipping its product on Tuesday. India-based Dr. Reddy's says its semaglutide has already arrived in "select" Canadian pharmacies and will be available more widely across the country in the coming days. Apotex says its generic semaglutide will be approximately one-third the price of Novo Nordisk's brand-name Ozempic. Ozempic can currently cost hundreds of dollars a month.